453 related articles for article (PubMed ID: 19355891)
1. Signaling through Rho GTPase pathway as viable drug target.
Lu Q; Longo FM; Zhou H; Massa SM; Chen YH
Curr Med Chem; 2009; 16(11):1355-65. PubMed ID: 19355891
[TBL] [Abstract][Full Text] [Related]
2. Role of the Rho-ROCK (Rho-associated kinase) signaling pathway in the regulation of pancreatic beta-cell function.
Hammar E; Tomas A; Bosco D; Halban PA
Endocrinology; 2009 May; 150(5):2072-9. PubMed ID: 19106222
[TBL] [Abstract][Full Text] [Related]
3. ROCK1 feedback regulation of the upstream small GTPase RhoA.
Tang AT; Campbell WB; Nithipatikom K
Cell Signal; 2012 Jul; 24(7):1375-80. PubMed ID: 22430126
[TBL] [Abstract][Full Text] [Related]
4. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
Shi J; Wei L
J Cardiovasc Pharmacol; 2013 Oct; 62(4):341-54. PubMed ID: 23921309
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells.
Feng X; Zhang L; Nie S; Zhuang L; Wang W; Huang J; Yan X; Meng F
Med Sci Monit; 2019 Oct; 25():7605-7616. PubMed ID: 31599230
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase as a therapeutic target in cardiovascular disease.
Surma M; Wei L; Shi J
Future Cardiol; 2011 Sep; 7(5):657-71. PubMed ID: 21929346
[TBL] [Abstract][Full Text] [Related]
7. The Rho GTPase signalling pathway in urothelial carcinoma.
Woldu SL; Hutchinson RC; Krabbe LM; Sanli O; Margulis V
Nat Rev Urol; 2018 Feb; 15(2):83-91. PubMed ID: 29133936
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase as a therapeutic target in vascular diseases: striking nitric oxide signaling.
Kolluru GK; Majumder S; Chatterjee S
Nitric Oxide; 2014 Dec; 43():45-54. PubMed ID: 25196952
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Microglial Phagocytosis by RhoA/ROCK-Inhibiting Drugs.
Scheiblich H; Bicker G
Cell Mol Neurobiol; 2017 Apr; 37(3):461-473. PubMed ID: 27178562
[TBL] [Abstract][Full Text] [Related]
10. [Advances in the study of Rho kinase and its inhibitors].
Duan WG; Yuan ST; Liao H; Yan M; Zhang LY
Yao Xue Xue Bao; 2007 Oct; 42(10):1013-22. PubMed ID: 18229604
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase.
Krijnen PA; Sipkens JA; Molling JW; Rauwerda JA; Stehouwer CD; Muller A; Paulus WJ; van Nieuw Amerongen GP; Hack CE; Verhoeven AJ; van Hinsbergh VW; Niessen HW
J Mol Cell Cardiol; 2010 Nov; 49(5):781-90. PubMed ID: 20691698
[TBL] [Abstract][Full Text] [Related]
12. Rho Kinases in Autoimmune Diseases.
Pernis AB; Ricker E; Weng CH; Rozo C; Yi W
Annu Rev Med; 2016; 67():355-74. PubMed ID: 26768244
[TBL] [Abstract][Full Text] [Related]
13. Approaches of targeting Rho GTPases in cancer drug discovery.
Lin Y; Zheng Y
Expert Opin Drug Discov; 2015; 10(9):991-1010. PubMed ID: 26087073
[TBL] [Abstract][Full Text] [Related]
14. Effects of ethanol on RhoA/Rho-kinase-mediated calcium sensitization in mouse lung parenchymal tissue.
Aydinoglu F; Ergurhan Kiroglu O; Astarci E; Balli E; Ogulener N
Eur J Pharmacol; 2015 Oct; 764():318-327. PubMed ID: 26169563
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].
Nakayama M; Amano M; Kawabata S; Kaibuchi K; Takefuji M
Nihon Rinsho; 2004 Mar; 62 Suppl 3():202-6. PubMed ID: 15171369
[No Abstract] [Full Text] [Related]
16. Suppressive effect of Rho-kinase inhibitors Y-27632 and fasudil on spike-and-wave discharges in genetic absence epilepsy rats from Strasbourg (GAERS).
Çarçak N; Yavuz M; Eryiğit Karamahmutoğlu T; Kurt AH; Urhan Küçük M; Onat FY; Büyükafsar K
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1275-1283. PubMed ID: 30073384
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
Shimokawa H
J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
[TBL] [Abstract][Full Text] [Related]
19. Abl tyrosine kinase promotes dendrogenesis by inducing actin cytoskeletal rearrangements in cooperation with Rho family small GTPases in hippocampal neurons.
Jones SB; Lu HY; Lu Q
J Neurosci; 2004 Sep; 24(39):8510-21. PubMed ID: 15456825
[TBL] [Abstract][Full Text] [Related]
20. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
